Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062647
Status:
COMPLETED
Last Update Posted:
2019-01-16
First Post:
2003-06-09
Brief Title:
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia
Sponsor:
Cumberland Pharmaceuticals
Organization:
Cumberland Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08
Start Date Type:
None
Primary Completion Date:
2006-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08
Completion Date Type:
ACTUAL
First Submit Date:
2003-06-09
First Submit QC Date:
June 11 2003
Study First Post Date:
2003-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-03-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-14
Last Update Post Date:
2019-01-16
Last Update Post Date Type:
ACTUAL